경도인지장애, 알쯔하이머병에서 혈장 Homocysteine, Folate, Vitamin B12 농도와 인지기능
Serum Levels of Homocysteine, Folate, and Vitamin B12 and Cognitive Function in Mild Cognitive Impairment and Alzheimer’s Disease
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Objectives:This study aimed to investigate the serum levels of total homocysteine (tHcy), folate and vitamin B12 in Alzheimer’s disease and mild cognitive impairment. Methods:Sixty-one Alzheimer’s disease (AD) patients, forty mild cognitive impairment (MCI) patients and forty-four normal controls were studied. The serum homocysteine (tHcy), folate, and vitamin B12 were measured and MMSE-K, GDS were evaluated for cognitive function. Results:Serum tHcy levels were significantly higher and folate levels were lower in patients with AD than in controls. And also serum folate levels were lower in MCI than in controls. Vitamin B12 did not have a significant difference among three groups. The serum homocysteine and folate levels shows significant correlation with MMSE-K. Conclusion:Elevated tHcy levels and low blood levels of folate were associated with AD. Serum folate were significantly lower levels in MCI than in controls. We suggested that serum tHcy, folate are useful risk markers for the development of cognitive dysfunction.
Abstract
Objectives:This study aimed to investigate the serum levels of total homocysteine (tHcy), folate and vitamin B12 in Alzheimer’s disease and mild cognitive impairment. Methods:Sixty-one Alzheimer’s disease (AD) patients, forty mild cognitive impairment (MCI) patients and forty-four normal controls were studied. The serum homocysteine (tHcy), folate, and vitamin B12 were measured and MMSE-K, GDS were evaluated for cognitive function. Results:Serum tHcy levels were significantly higher and folate levels were lower in patients with AD than in controls. And also serum folate levels were lower in MCI than in controls. Vitamin B12 did not have a significant difference among three groups. The serum homocysteine and folate levels shows significant correlation with MMSE-K. Conclusion:Elevated tHcy levels and low blood levels of folate were associated with AD. Serum folate were significantly lower levels in MCI than in controls. We suggested that serum tHcy, folate are useful risk markers for the development of cognitive dysfunction.
참고문헌 (40)
- Benjamin J, "Kaplan & Sadock’s synopsis of psychiatry.10th ed", pp.329~331 (2007), Lipponcott Williams & Wilkins
- Kral VA, "Senescent forgetfulness: benign and malignant", Can Med Assoc J, 86, pp.257~260 (1962)
- Crook T, "Age associated memory impairment: proposed diagnositc criteria and measures of clinical change-report of a National Institute of Mental Health Work Group", Dev Neuropsychol, 2, pp.261~276 (1986)
- Levy R, "Aging-associated cognitive decline", Int Psychogeriatr, 6, pp.63~68 (1994)
- Graham JE, "Prevalence and severity of cognitive impairment with and without dementia in an elderly population", Lancet, 349, pp.1793~1796 (1997)
- Reisberg B, "The Global Deterioration Scale for assessment of primary degenerative dementia", Am J Psychiatr, 139, pp.1136~1139 (1982)
- Flicker C, "Mild cognitive impairment in the elderly: predictors of dementia", Neurology, 41, pp.1006~1009 (1991)
- Morris JC, "The Clinical Dementia Rating (CDR): current version and scoring rules", Neurology, 43, pp.2412~2414 (1993)
- Morris JC, "Mild cognitive impairment represents earlystage Alzheimer’s disease", Arch Neurol, 58, pp.397~405 (2001)
- Petersen RC, "Mild cognitive impairment: An overview", CNS Spectr, 13, pp.45~53 (2008)
- Mitchell AJ, "Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies", Acta Psychiatr Scand, 119, pp.252~265 (2009)
- Vogel T, "Homocysteine, vitamin B12, folate and cognitive function: a systematic and critical review of the literature", Int J Clin Pract, 63, pp.1061~1067 (2009)
- Malaguarnera M, "Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease", Clin Chem Lab Med, 42, pp.1032~1035 (2004)
- Köseoglu E, "Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease", Clin Biochem, 40, pp.859~863 (2007)
- Quadri P, "Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia", Am J Clin Nutr, 80, pp.114~122 (2004)
- Ariğul S, "Vitamin B12,folate, homocysteine and dementia: are they really related?", Arch Geriatr, 40, pp.139~146 (2005)
- Ravaglia G, "Elevated plasma homocysteine levels in centernarians are not associated with cognitive impairment", Mech Ageing Dev, 121, pp.251~261 (2000)
- Durga J, "Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind,controlled trial", Lancet, 369, pp.208~216 (2007)
- Sommer BR, "Folic acid supplementation in dementia:a preliminary report", J Geriatr Psychiatry Neurol, 16, pp.156~159 (2003)
- McMahon JA, "A controlled trial of homocysteine lowering and cognitive performance", N Engl J Med, 354, pp.2764~2772 (2006)
- Hvas AM, "No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study", J Affect Disord, 81, pp.269~273 (2004)
- Lewerin C, "Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study", Am J Clin Nutr, 81, pp.1155~1162 (2005)
- Eussen SJ, "Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial", Am J Clin Nutr, 84, pp.361~370 (2006)
- American Psychiatric Association, "Diagnostic and statiscal manual of mental disorder", American Psychiatric Association, ~ (1994)
- McKhann G, "Clinical diagnosis of Alzheimer’s disease: report of NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
- 권용철, "노인용 한국판 Mini-Mental State Examination (MMSE-K)의 표준화 연구-제1편: MMSE-K의 개발", 신경정신의학, 28, pp.125~135 (1989)
- Reisberg B, "The Global Deterioration Scale for assessment of primary degenerative dementia", Am J Psychiatry, 139, pp.1136~1139 (1982)
- Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiat, 23, pp.56~61 (1960)
- Clarke R, "Folate,vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease", Arch Neurol, 55, pp.1449~1455 (1998)
- Mcilroy SP, "Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland", Stroke, 33, pp.2351~2356 (2002)
- Lipton SA, "Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor", Proc Natl Acad Sci U S A, 94, pp.5923~5928 (1997)
- De La Torre JC, "Cerebral hypoperfusion, capillary degeneration and development of Alzheimer disease", Alzheimer Dis Assoc Disord, 14(Suppl 1), pp.S72~81 (2000)
- Hamel E, "Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer’s disease", Exp Physiol, 93, pp.116~120 (2008)
- Zhang CE, "Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain", Am J Pathol, 174, pp.1481~1491 (2009)
- Zhang CE, "Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus", Neurobiol Aging, 29, pp.1654~1665 (2008)
- Williams JH, "Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people", Age Ageing, 31, pp.440~444 (2002)
- Piazza F, "Increased tissue factor pathway inhibitor and homocysteine in Alzheimer’s disease", Neurobiol Aging, ~ (2010)
- Gallucci M, "Homocysteine in Alzheimer disease and vascular dementia", Arch Gerontol Geriatr, (Suppㅣ9), pp.195~200 (2004)
- Religa D, "Homocysteine, apolipoprotein E and methylenetetrahydrofolate reductase in Alzheimer’s disease and mild cognitive impairment", Dement Geriatr Cogn Disord, 16, pp.64~70 (2003)
- De Silva HA, "Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer’s disease", Exp Aging Res, 31, pp.345~354 (2005)
